CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in MDGL — Madrigal Pharmaceuticals, Inc.
CIK 884546
SAN FRANCISCO, CA
Position in MDGL
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$98,972,771
-$14,473,647 QoQ
Shares Held
184,324
-14.9% QoQ
Ownership
0.798%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#28
of 411 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MDGL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $7,346,663,053 across 299 Biotechnology names. MDGL ranks #18 (1.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,041,282 | $1,013,966,007 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
846,306 | $527,705,642 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
1,917,025 | $359,020,441 | |
| 4 | MRNA |
Moderna, Inc.
|
4,838,884 | $338,867,045 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
755,377 | $227,391,137 | |
| 6 | INCY |
Incyte Corp
|
1,692,439 | $191,854,884 | |
| 7 | RPRX |
Royalty Pharma plc
|
3,083,528 | $172,893,414 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,565,781 | $133,388,883 |
All Filings in MDGL
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $98,972,771 | 184,324 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $113,446,418 | 216,720 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $127,590,111 | 219,099 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $97,993,626 | 213,652 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $46,329,644 | 153,085 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $50,098,868 | 151,251 | Shares | Sole | 2025-09-15 | |
| 2024-12-31 | $46,515,693 | 150,746 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $31,402,193 | 147,970 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $38,750,050 | 138,314 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $32,763,671 | 122,692 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $27,814,652 | 120,212 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $15,991,526 | 109,501 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $22,734,558 | 98,418 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $22,196,345 | 91,622 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $26,543,362 | 91,450 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $5,815,240 | 89,479 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $6,316,935 | 88,250 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $8,681,068 | 88,474 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $7,348,483 | 86,718 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $6,612,037 | 82,868 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $7,040,989 | 72,282 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $7,528,072 | 64,359 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $6,691,099 | 60,188 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $7,042,469 | 59,315 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $6,978,691 | 61,622 | Shares | Sole | 2020-08-20 | |
| 2020-03-31 | $3,888,102 | 58,240 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||